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Lower cardiac vagal control (CVC) has been linked to greater depression. However, this link has not
been consistently demonstrated, suggesting the presence of key moderators. Sleep plausibly is one
such factor. Therefore, we investigated whether sleep quality moderates the link between CVC
(quantified by high-frequency heart rate variability, HF-HRV) and depressive symptoms (assessed
using established questionnaires) in 29 healthy women. Results revealed a significant interaction
between HF-HRV and sleep quality in predicting depressive symptoms: participants with lower HF-
HRV reported elevated depressive symptoms only when sleep quality was also low. In contrast, HF-
HRV was not associated with depressive symptoms when sleep quality was high, suggesting a
protective function of high sleep quality in the context of lower CVC.
Low cardiac vagal control (CVC), typically assessed by heart rate variability related to respira-
tion (respiratory sinus arrhythmia), has been linked with various mental health outcomes and
particularly with diagnosis and symptoms of depression (e.g., Rottenberg, 2007). But while
several empirical findings have supported an inverse relationship between CVC and depressive
symptoms (e.g., Agelink et al., 2001), other studies have revealed no or even the opposite pattern
of results (e.g., Lehofer et al., 1997). This suggests there might be moderators of the link
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between CVC and depressive symptoms. In the following, we will consider sleep quality as an
important factor that may help explain the inconsistent links between CVC and depressive
symptoms. Reduced sleep quality has emerged as an important risk factor in a variety of physical
and mental health conditions including depression (see Imeri & Opp, 2009; Taylor, Lichstein, &
Durrence, 2003), whereas high sleep quality may well have the potential to protect against
elevated depressive symptoms in individuals with lower CVC.
CARDIAC VAGAL CONTROL AND DEPRESSIVE SYMPTOMS
CVC is linked to the functioning of one branch of the autonomic nervous system—the
parasympathetic system—which is believed to subserve broad homeostatic functions (e.g.,
Berntson et al., 1997; Grossman & Taylor, 2007). The parasympathetic system influences
heart rate via the vagus nerve, which originates in the brain stem and projects to many organs,
including the heart. Respiratory sinus arrhythmia reflects the variation in heart rate that is related
to the respiratory cycle and is thought to index CVC (e.g., Berntson et al., 1997).
Empirical evidence for the link between CVC and depression often supports a relationship
between lower CVC and greater depressive symptoms (e.g., Licht et al., 2008; Rottenberg,
2007). Specifically, it has been shown that lower levels of resting CVC are related to higher
depressive symptoms in participants with clinical depression (e.g., Agelink et al., 2001), remitted
depression (e.g., Licht et al., 2008), and in healthy but high-risk population groups (Gentzler,
Rottenberg, Kovacs, George, & Morey, 2011) as well as in healthy participants (Hopp et al.,
2013). However, other studies have found no relationship (e.g., Gentzler, Santucci, Kovacs, &
Fox, 2009; Lehofer et al., 1997) or even the opposite pattern showing, for example, higher CVC
in depressed (vs. healthy) women (e.g., Thayer, Smith, Rossy, Sollers, & Friedman, 1998) or
non-recovering depressed patients (Rottenberg, Wilhelm, Gross, & Gotlib, 2002). Overall,
although the literature rather supports a negative link between reduced CVC and higher
depressive symptoms, especially when including the meta-analysis by Rottenberg (2007),
there are still studies showing positive links or no relationship between CVC and depressive
symptoms. These findings suggest that there might be factors moderating the link between CVC
and depressive symptoms.
SLEEP AS A MODERATOR OF THE LINK BETWEEN CVC AND DEPRESSIVE
SYMPTOMS
One plausible moderator in the link between CVC and depressive symptoms is sleep. Individuals
with severe sleep disturbances show a two- to fourfold risk for developing clinical depression
(see Riemann, Berger, & Voderholzer, 2001). This points to the possibility for high sleep quality
being a protective factor in the development of depressive symptoms. One longitudinal study
provided support for this idea by showing that resilient young adults who did not develop
depressive symptoms (despite low socioeconomic status) demonstrated shorter sleep latency and
enhanced deep sleep (both indicators of better sleep) during childhood (Silk et al., 2007).
Although the exact functions of sleep remain unknown, there is increasing evidence that sleep
facilitates self-regulatory as well as neurophysiological processes (e.g., Barber & Munz, 2010) in
452 WERNER ET AL.
order to support a more adaptive and flexible control of behavior, attention, and emotion (e.g.,
Walker, 2010). In contrast, poorer sleep quality may impair individuals’ ability to regulate
behavior and emotions by increased arousal (e.g., Riemann et al., 2010) and by disrupting
higher cognitive functions which support self-regulatory processes such as cognitive emotion
regulation (Mauss, Troy, & LeBourgeois, 2013). Consequently, for individuals whose reduced
levels of CVC put them at risk for increased depressive symptoms by increased arousal and by
impairing self-regulatory abilities, high sleep quality may provide additional regulatory
resources and offset this risk. In other words, CVC and sleep quality might interact with one
another, such that CVC is associated with higher depressive symptoms only in the presence of
low but not high sleep quality.
Studies investigating the link between CVC and depressive symptoms have just started to
take sleep quality into account, mainly in clinical samples (Bylsma, Salomon, Taylor-Clift,
Morris, & Rottenberg, 2014; Yang et al., 2011). These studies support the idea that sleep may
play a role in the link between CVC and depressive symptoms by showing, for example, links
between reduced sleep quality and reduced CVC in depressed but not in healthy individuals
(Yang et al., 2011). One study directly tested the model we propose here, whereby CVC and
sleep quality interact in predicting depressive symptoms. This study provided evidence for a
moderating role of sleep in healthy children between the ages of 8 and 9 years (El-Sheikh, Erath,
& Keller, 2007). It showed that low levels of CVC were only linked with greater depressive
symptoms in the context of low sleep quality. To date, no study has investigated this relationship
in adults.
THE PRESENT STUDY
The present study was designed to examine sleep quality as a moderating factor in the relation-
ship between CVC and depressive symptoms. It did so by testing, in a generally healthy adult
sample, the interaction between trait-level resting CVC and subjective sleep quality in predicting
depressive symptoms. Because both CVC and sleep vary across the lifespan and between
genders (e.g., Carrier, Land, Buysse, Kupfer, & Monk, 2001; De Meersman & Stein, 2007),
this first study in adults involved only young women to reduce these sources of variance. We
assessed CVC by quantifying heart rate variability in the high-frequency spectral band (HF-
HRV; Berntson et al., 1997) during an extended resting baseline in order to enhance reliability.
To standardize mental activity and ensure a neutral character of this baseline assessment, we
used a minimally demanding task in the form of a neutral film (as recommended by Jennings,
Kamarck, Stewart, Eddy, & Johnson, 1992). Furthermore, it has been recommended to use a
second baseline measurement when assessing resting CVC to estimate its consistency across
situations (Bertsch, Hagemann, Naumann, Schachinger, & Schulz, 2012). Therefore, we
included a second baseline, the 2-min prefilm baseline (quiet sitting before the neutral film
started) to confirm that this would provide the same results. We used established questionnaires
to measure subjective sleep quality (Pittsburgh Sleep Quality Index; Buysse, Reynolds, Monk,
Berman, & Kupfer, 1989) and current depressive symptoms (German version of the Center for
Epidemiologic Studies Depression Scale; Hautzinger & Bailer, 1993).
We expected subjective sleep quality to interact with CVC (as indexed by HF-HRV) in
predicting depressive symptoms. Specifically, we expected lower CVC to predict higher
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depressive symptoms only in the context of low sleep quality, but not in the context of high sleep
quality, indicating a protective function of high sleep quality.
METHOD
Participants
Participants were 29 healthy female undergraduates (University of Salzburg, all Caucasian) aged
between 19 and 31 years (M = 23.6 years, SD = 3.3) with a body mass index (BMI) between
17.4 and 31.7 (M = 21.8, SD = 3.5). The participants were non- or only occasional smokers with
no known history of mental, neurological, or sleep disorders.
Procedure
The investigation took place as part of a larger study in the Clinical Stress and Emotion Lab of
the University of Salzburg (for further details see Werner, Ford, et al., 2015; Werner, Schabus,
Blechert, Kolodyazhniy, & Wilhelm, 2015) including four visits to the lab (entrance examination
and three nights in the lab). The whole study spanned 11 days. Participants were asked to
complete daily sleep diaries to assure regular sleep cycles throughout the study. The study started
with the entrance examination, during which participants completed several questionnaires,
including the assessment of subjective sleep quality (referring to the prior four weeks), depres-
sive symptoms (referring to the prior week), as well as general medical and psychological health
condition. Specifically, physical fitness was rated on a 4-point Likert scale, 1 (not very active) to
4 (physical activity three times a week or more), and body mass index (BMI) was computed
using participants’ self-reported height and weight. The entrance examination was followed by
three nights in the lab. The first night was used as an adaptation night. Night two and three
included either the presentation of one completely neutral or one aversive film before partici-
pants went to bed; this was counterbalanced across participants.
The focus of the present investigation was the measurement of CVC (indexed by HF-HRV)
during the presentation of the feature-length neutral film and the prefilm baseline, in relation to
subjectively reported sleep quality and depression symptoms.1 Participants were seated on a
chair placed 40 inches in front of a 24-inch full HD monitor, and electrodes and sensors for
measuring cardiovascular activity were attached. They were monitored by the experimenters,
who were instructed to call the participants by name whenever they had the feeling that the
participant would be drifting off. During film viewing (see description below), cardiovascular
activity was recorded. Stimulus presentation of the film was controlled by E-Prime 2.0
(Psychology Software Tools, Inc., Pittsburgh, PA, USA). The study was approved by the local
ethics committee. Participants signed written informed consent before the study and were
compensated with course credit or payment of 100 Euro after the last session of the whole
study period.
1 Results concerning pre-to postsleep changes in emotional reactivity to the aversive film in relation to REM sleep,
and regarding links between resting CVC (wake as well as sleep stage related) and sleep quality (subjective as well as
objective variables) have been reported separately (Werner, Ford, et al., 2015; Werner, Schabus, et al., 2015).
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Measures
HF-HRV
Psychophysiological measurements during the neutral film and the prefilm baseline were
recorded using a 32-channel amplifier (TMSi, EJ Oldenzaal, The Netherlands) and the recording
software package Polybench 1.22 (TMSi) with a sampling rate of 1024 Hz and 22-bit resolution.
The recordings contained electrocardiogram (ECG), for which alcohol pads were used to clean
the skin sites. ECG was recorded using disposable 55-mm diameter solid-gel snap electrodes; the
electrodes were applied on the upper sternum and lowest rib on the left side. A 0.05 Hz high-
pass filter was applied during ECG measurement. After recording, ECG raw data were bandpass
filtered between 0.5 and 40 Hz and further processed using the software Autonomic Nervous
System Laboratory (ANSLAB) version 2.51 (Wilhelm, Grossman, & Roth, 1999); R-spikes
were determined automatically by ANSLAB and further manually checked. In ANSLAB, the
preprocessed ECG was analyzed with power spectral analyses between .15 Hz and .40 Hz. More
specifically, to obtain HF-HRV values, heart-period time series were linearly detrended and
resampled at 4 Hz using cubic spline interpolation. Then, power-spectral densities for the whole
duration of the neutral film (94 min) were computed using the Welch algorithm, which creates
ensemble averages of successive periodograms. The averages were derived from spectra esti-
mated for 120-s segments, overlapping by half. For each 120-s segment, we analyzed 512 points,
which includes 480 sampled points with zero padding. We used Hanning-windowed segments
that were subjected to fast Fourier transform. Estimates of power were adjusted to account for
attenuation produced by the Hanning window, and distribution characteristics were normalized
by natural-logarithm transformation. Although associations between vagal activity and HF-HRV
might be influenced by variables like respiratory rate (e.g., Grossman & Taylor, 2007), we did
not adjust for respiration, as this is less useful for individual difference analyses because people
might differ in respiratory function due to factors unrelated to CVC, such as basal metabolic rate
and respiratory pacemaker function (Grossman & Taylor, 2007). However, we did control for
other possible confounding factors like age, BMI, and physical fitness. We used BMI as
additional, interval-scaled proxy for physical fitness, as research often shows inverse links
between BMI and physical fitness (e.g., Nikolaidis, 2013), which in turn can be linked to
sleep quality and HF-HRV.
We used a neutral film to measure HF-HRV. We chose the neutral documentary Living in a
Monastery (Spiegel TV, 94 min),2 which describes the daily routine of nuns in a convent without
any positive or negative emotional content. The film was validated in a pilot study with 11 female
participants (age: M = 21.8, SD = 2.0) who provided valence ratings (1 = positive; 9 = negative)
and arousal ratings (1 = not arousing, 9 = very arousing). Participants rated the film neutral to
slightly positive (M = 3.4, SD = 1.6) and minimally arousing (M = 2.5, SD = 1.5). Additionally, we
used the 2-min prefilm baseline (quiet sitting before the neutral film) as a comparison condition to
enhance confidence in the results.
2 This German documentary can be found on the Web page of the television channel SpiegelTV (http://www.spiegel.
tv/filme/kloster-leben-verliebt-gott/).
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Subjective sleep quality
We chose the Pittsburgh Sleep Quality Index (Buysse et al., 1989; German version by
Riemann & Backhaus, 1996) to measure overall subjective sleep quality. The PSQI is a self-
report questionnaire assessing sleep quality and sleep disturbances over the preceding 4-week
time interval. Eighteen individual items generate seven “component” scores (each with values
between 0 and 3): subjective sleep quality, sleep latency, sleep duration, habitual sleep effi-
ciency, sleep disturbances, use of sleeping medication, and daytime dysfunction. These scores
are summed up to obtain one global measure of subjective sleep quality (0–21). Lower values in
the PSQI indicate better subjective sleep quality. The suggested clinical cutoff value for good
subjective sleep quality in the PSQI is 5.
Depressive symptoms
To measure subclinical depressive symptoms in our healthy sample, we used the German
version of the Center for Epidemiologic Studies Depression Scale (ADS: Hautzinger & Bailer,
1993; Hautzinger, Bailer, Hofmeister, & Keller, 2012; CESD: Radloff, 1977). This questionnaire
has 20 items and refers to the preceding week. It includes emotional, motivational, somatic, and
motoric-interactional complaints (e.g., “I did not feel like eating; my appetite was poor”; “I felt
sad”) on a 4-point scale from 0 (rarely or none of the time/less than 1 day during the last week)
to 3 (most or all of the time/5–7 days during the last week), which leads to a maximum
depression score of 60. Higher scores indicate higher depression severity with values above
22 indicating clinically relevant depressive symptoms (Hautzinger et al., 2012). The German
version of the CESD has demonstrated good internal consistency in the present sample (α = .89)
and has been shown to be highly correlated (.72 < rs < .94) with other self-report questionnaires
for depressive symptoms such as the Beck Depression Inventory (Hautzinger & Bailer, 1993).
Statistical Analysis
First, because most variables were non-normally distributed (Kolmogorov-Smirnov,
Lilliefors < .05) or ordinally coded (subjective sleep quality, physical activity), we used
Spearman correlations to investigate interrelationships between both HF-HRV variables
and PSQI, depressive symptoms, as well as confounding variables (i.e., age, BMI, physical
fitness). Only for the correlation of HF-HRV during the neutral film (HF-HRV film) with
HF-HRV during the prefilm baseline (HF-HRV baseline) Pearson correlations were used.
Second, we conducted linear regression models with HF-HRV, PSQI, and the interaction
term between HF-HRV and PSQI (all independent variables were mean-centered) as
separate predictors for depressive symptoms. This analysis remains appropriate given
that it only requires normally distributed errors and homoscedasticity—which are present
in the current data—and does not require normally distributed predictors (Field, 2009).
Model 1 included HF-HRV film, whereas HF-HRV baseline was used in Model 2. We also
report both models when including confounding variables as additional predictors.
Finally, we conducted an exploratory analysis to exclude the possibility that a mediation
model accounts better for the data structure. We tested the indirect effect of HF-HRV on
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depressive symptoms (i.e., CESD) via sleep quality (i.e., PSQI) using the PROCESS model (see
Hayes, 2013). All analyses were run using IBM SPSS 22.
RESULTS
Preliminary Analysis
Descriptive statistics for HF-HRV variables, subjective sleep quality, and depressive symptoms
are summarized in Table 1. The means of depressive symptoms and sleep quality were in the
normal range. Three participants (10%) exceeded the clinical cutoff (> 22) of the depression
scale, indicating clinically relevant depressive symptoms. On the subjective sleep quality scale,
four participants (14%) revealed values above the suggested cutoff (> 5) for insomnia.
Nevertheless, we included all participants in the analyses, as these values are only clinically
relevant values, but no statistical outliers (> 3 SDs), so as to not artificially restrict variance in
these variables of interest.
Table 1 also presents zero-order relationships among HF-HRV variables, sleep quality,
depressive symptoms, and possible confounding factors (age, BMI, and physical fitness). The
two HF-HRV variables were highly correlated, indicating transsituational consistency of HF-
HRV. Lower HF-HRV for the film but not the prefilm baseline condition was significantly
related to lower sleep quality (i.e., higher PSQI scores; however with low multicollinearity:
tolerance > .89, VIF < 1.12). Lower HF-HRV for the film as well as for the prefilm baseline
condition was significantly related to higher depressive symptoms. Lower sleep quality was also
related to higher depressive symptoms. None of the possible confounding variables were
significantly related to both HF-HRV variables, sleep quality, or depressive symptoms.
TABLE 1
Descriptives and Zero-Order Correlations for Study and Control Variables








CVC film (HF-HRV, ms2) 8.17 1.02 – – – –
CVC baseline (HF-HRV, ms2) 8.44 1.14 .87*** – – –
Sleep quality (PSQI, 1–21) 4.10 (4) 1.37 (1–7) –.39* –.28 – –
Depressive symptoms (CESD, 0–
60)
11.31 7.76 –.55*** –.49** .64*** –
Control variables
Age (years) 23.55 3.30 .09 .01 –.07 .08
BMI (kg/m2) 21.80 3.50 .13 .19 –.05 .01
Physical fitness (0–4) 2.66 (3) 0.90 (1–4) .15 –.05 .05
Note. N = 29. Pearson correlation for CVC film with CVC baseline; Spearman correlations for all other variables. For PSQI
and physical fitness (ordinal-scaled) we also report the median and range in parentheses. Larger values in the PSQI indicate worse
sleep quality. CVC = cardiac vagal control, HF-HRV = high-frequency heart rate variability, PSQI = Pittsburgh Sleep Quality
Index, CESD = Center for Epidemiologic Studies Depression Scale (German version), BMI = Body Mass Index.
*p ≤ .05, **p ≤ .01, ***p ≤ .001.
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Sleep Quality as Moderator in the Relationship Between HF-HRV and Depressive
Symptoms
To test the hypothesis that subjective sleep quality acts as a moderator in the relationship
between HF-HRV and depressive symptoms, we conducted linear regression analyses. Model 1
included depressive symptoms as dependent variable as well as HF-HRV film (HF-HRV
during the prefilm baseline, in the following referred to as HF-HRV baseline, in Model 2),
subjective sleep quality, and the interaction of the two as independent variables (all indepen-
dent variables were mean-centered). HF-HRV and subjective sleep quality were entered in
block 1, and the interaction was entered in block 2. The results of the regression analyses for
both models are displayed in Table 2. In Model 1, lower HF-HRV film was marginally related
to higher depressive symptoms, whereas in Model 2 this relationship was significant. In both
models, lower sleep quality was significantly related to higher depressive symptoms.
Importantly, in both models these main effects were qualified by a significant interaction;
for the addition of the interaction term to Model 1 (block 2), the change in R2 was significant,
R2change = .11, F(1, 25) = 6.06, p = .021; this effect was even stronger for Model 2,
R2change = .16, F(1,25) = 10.15, p = .004.
To illustrate the interaction, the relationship was plotted using mean values ±1 standard
deviation of subjective sleep quality and HF-HRV (see Figure 1; only the interaction of
Model 1 was plotted as results in Model 2 were equivalent). Simple slope analyses revealed
that for participants with higher sleep quality (low PSQI scores), HF-HRV did not predict
depressive symptoms, β = .06, t(28) = .31, p = .756 (Model 2: β = .01, t(28) = .08, p = .934).
However, for participants with lower sleep quality (high PSQI scores), lower HF-HRV signifi-
cantly predicted higher depressive symptoms, β = –.61, t(28) = -3.04, p = .005 (Model 2: β =
–.78, t(28) = –3.96, p ≤ .001). Additionally, individuals with higher HF-HRV reported the same
amount of depressive symptoms whether they reported high or low sleep quality, β = .25, t(28) =
1.43, p = .165 (Model 2: β = .17, t(28) = 1.00, p = .328), whereas individuals with lower HF-
HRV reported significantly more depressive symptoms when they were low (vs. high) in sleep
quality, β = .92, t(28) = 4.14, p ≤ .001 (Model 2: β = .96, t(28) = 4.94, p ≤ .001). These results
TABLE 2
Current Depressive Symptoms (CESD) as Predicted by Cardiac Vagal Control (HF-HRV Film and Baseline) and
Subjective Sleep Quality (PSQI)
B SE CI (l; u) β t p
Model 1
CVC (HF-HRV film) –2.07 1.10 –4.33; 0.19 –.27 –1.88 .071
Sleep quality (PSQI) 3.33 0.84 1.60; 5.07 .59 3.96 .001
CVC x sleep quality –1.85 0.75 –3.40; –0.30 –.35 –2.46 .021
Model 2
CVC (HF-HRV baseline) –2.61 0.91 –4.48; –0.73 –.38 –2.87 .008
Sleep quality (PSQI) 3.19 0.75 1.65; 4.74 .56 4.25 .001
CVC x sleep quality –1.97 0.62 –3.24; –0.70 –.42 –3.19 .004
Note. N = 29. Adjusted R2 for Model 1 = .48, for Model 2 = .56. CVC and sleep quality were always entered in step 1 of the
regression analyses, whereas the interaction term was entered in step 2 to obtain separate statistical values for this addition to the
model. HF-HRVand PSQI are mean-centered. For abbreviations, see Table 1.
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indicate that participants reported higher depressive symptoms only when exhibiting both low
HF-HRV and low subjective sleep quality.3
Next, we included age, BMI, and physical fitness as predictors in step one in the same regression
analyses (Model 1 and 2). Although these variables revealed no significant correlations with our
variables of interest, they are theoretically important and might have non-significant confounding
effects on HF-HRV and sleep quality. When including age, BMI, and physical fitness in the
analyses, the interaction of HF-HRV film and sleep quality became marginally significant (R2
change = .08, F[6, 28] = 4.00, p = .058) whereas the interaction between HF-HRV baseline and
sleep quality remained significant (R2 change = .12, F[6, 28] = 7.12, p = .014).
Mediation Model
Given that HF-HRV film (but not HF-HRV during the prefilm baseline), sleep quality and
depressive symptoms were associated with each other in zero-order correlations, a mediation of
the HF-HRV-depression relationship by sleep quality would be a possible alternative way of
interpreting the data. To test this possibility, we examined the indirect effect of HF-HRV film on
FIGURE 1 The interaction of high-frequency heart rate variability (HF-HRV during the neutral film) and
subjective sleep quality (i.e., PSQI) on current depressive symptoms (total score on the German version of the
Center for Epidemiologic Studies Depression Scale; CESD). Values show estimates at means ±1 SD for HF-HRV
film and sleep quality, and error bars represent corresponding standard errors. Asteriks denote slopes that are
significantly different from zero (*p ≤ .05, **p ≤ .01, ***p ≤ .001).
3 The pattern of results (in Model 1 and Model 2, for HF-HRV during the neutral film as well as the prefilm baseline
condition) remained also unchanged when excluding the sleep-related item within the CESD. This was done in order to
get a measure of depressive symptoms that was free of reduced sleep quality. Furthermore, one participant used allergy
medications, known to have anticholinergic properties and thus potentially influencing HF-HRV assessment. We
reanalyzed our data without this participant and the results remained the same. Lower HF-HRV during sleep and
lower sleep quality (higher scores in the PSQI) were still significantly related to higher depressive symptoms. Most
importantly, these main effects were qualified by a significant interaction; for the addition of the interaction term to the
Model (in step 2), the change in R² was significant, R²change = .12, F(1, 25) = 5.79, p = .024.
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depressive symptoms via subjective sleep quality. This indirect effect was computed using 95% bias
corrected bootstrap confidence intervals, with 10.000 bootstrap samples. Results showed that the
indirect effect was not statistically different from zero [95% CI: –3.83 – .10], Sobel´s z = –1.50, p =
.132, indicating that a mediation model did not provide a better fit to the data structure.
DISCUSSION
Although theoretical considerations suggest that lower CVC is linked to higher depressive
symptoms, empirical evidence is mixed. This points to the existence of moderating factors.
Therefore, the present study examined the effect of sleep quality as a moderator in the link
between CVC (measured via HF-HRV) and depressive symptoms. Sleep quality is a plausible
moderator because sleep quality (a) has a protective effect on depressive symptoms and (b) is
thought to have those effects in part via a mechanism similar to that of CVC: self-regulation. We
measured HF-HRV with two different assessments in order to enhance transsituational consis-
tency of the effects of HF-HRV. Results for both HF-HRVassessments showed that sleep quality
functioned as a moderator in the relationship between HF-HRV and depressive symptoms.
Participants with lower HF-HRV showed elevated depressive symptoms only when they also
reported lower sleep quality, whereas participants with lower HF-HRV did not show elevated
depressive symptoms when they reported high sleep quality.
Because we found simple relationships among HF-HRV, sleep quality, and depression, we
also tested a mediation model, wherein HF-HRV is linked to depressive symptoms via sleep
quality. There was no statistical support for this model, which further bolstered confidence in the
moderation model. These findings extend prior research in children (El-Sheikh et al., 2007) in
emphasizing the important role of sleep quality as a protective factor in the relationship between
HF-HRV and depressive symptoms.
Theoretical Implications: CVC, Sleep Quality, and Depressive Symptoms
Research on CVC and depression suggest that lower CVC is a physiological marker and risk
factor related to the occurrence of increased depressive symptoms (e.g., Rottenberg, 2007).
Recent theories explain these correlates of CVC within an evolutionary perspective linking CVC
with arousal-related processes, such as adaptive behavioral strategies. In particular, it has been
proposed that CVC is a concomitant of self-regulation and specifically emotion regulation in
mammals (Porges, 2001; Thayer & Lane, 2000). Thus, they provide a biopsychosocial frame-
work for interpreting CVC differences in, for example, mood disorders (Rottenberg, 2007).
However, as empirical evidence is mixed, it has been suggested that moderating factors may
influence the relationship between CVC and depressive symptoms (e.g., El-Sheikh et al., 2007;
Yang et al., 2011).
We proposed that sleep quality may be a particularly plausible moderating factor, and the
present results support this idea. Why might good sleep protect individuals from the risk
associated with low CVC? One potential reason is that sleep provides additional resources for
self-regulatory, and especially emotion-regulatory, processes, which are commonly impaired in
depression (e.g., Hofmann, Sawyer, Fang, & Asnaani, 2012). Sleep disturbances and even
mildly decreased sleep quality disrupt higher cognitive functions that may support emotion
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regulation (Mauss et al., 2013). Moreover, sleep deprivation (an analogue to severe sleep
disturbances) reduces functional connectivity between brain regions related to cognitive control
and emotional responses (e.g., medial prefrontal cortex, amygdala; Yoo, Gujar, Hu, Jolesz, &
Walker, 2007). This may reflect decreased prefrontal control of emotions. Thus, it is possible
that higher sleep quality may offset the risk for depressive symptoms imposed by reduced CVC,
by facilitating emotion regulation.
Practical Implications
Our results provide support for a model regarding the development of depressive symptoms in
which CVC and one’s sleep quality are critically important. With a lifetime prevalence of around
16.2% (Kessler et al., 2003) and recurrence rates between 35% in the general population and
85% in specialized mental health facilities (Hardeveld, Spijker, De Graaf, Nolen, & Beekman,
2010), affective disorders (mainly major depression) belong to the second most frequent group
of disorders (Wittchen & Jacobi, 2005). Therefore, early intervention in individuals with mild
depressive symptoms—and prevention of major depressive disorder before it emerges—is of
crucial importance for public health.
Although three participants exceeded the clinical cutoff of 22 points on the CESD, our study
included mostly healthy participants with minimal to subclinical levels of depressive symptoms.
Focusing on healthy participants (vs. clinical samples) provides valuable insights and extends
knowledge on how to improve mental health before clinical disorders occur. It has been
suggested that depression is best conceptualized on a continuum, and that clinical depression
is not categorically distinct from milder forms of depressive symptoms occurring in generally
healthy individuals (Rodriguez, Nuevo, Chatterji, & Ayuso-Mateos, 2012). Furthermore, it
seems that even individuals with subclinical levels of depressive symptomatology can exhibit
significant decrements in overall health, well-being, and daily functioning (Ayuso-Mateos,
Nuevo, Verdes, Naidoo, & Chatterji, 2010). Thus, the present study has important implications
for the prevention of clinically relevant depressive symptoms.
One set of practical implications of the present study concerns CVC. CVC can be improved via
biofeedback (e.g., Nolan et al., 2005), leading to a reduction of depressive symptoms (Siepmann,
Aykac, Unterdorfer, Petrowski, & Mueck-Weymann, 2008). CVC can also be enhanced by pharma-
cological and surgical means (Bernik et al., 2002; Singh, Kandala, & Camm, 2014). Interestingly, Tsai,
Kuo, Lee, and Yang (2015) showed that slow-paced breathing (at a frequency of 0.1 Hz) can lead to
increases in CVC as well, which improved sleep quality among individuals with insomnia.
Furthermore, increasing physical exercise over a period of 6 months, which is very likely to increase
CVC, has also been shown to have positive effects on sleep quality and depression as well as mood in
general (Hartescu, Morgan, & Stevinson, 2015; Passos et al., 2011). The present study suggests that
such efforts would be especially important in individuals with low resting CVC and low sleep quality.
A second set of practical implications concerns sleep. Our results suggest that improving
sleep quality in individuals complaining about sleep problems is a crucial step for supporting
mental health (Buysse, 2014). Higher sleep quality might buffer other risk factors like decreased
CVC, at least in otherwise healthy individuals. Sleep interventions may be even more important
than CVC interventions, as they are probably easier to implement. Research in clinical samples
already showed that even short-term interventions (one session of cognitive behavioral therapy
for insomnia) can improve sleep quality considerably and for at least 4 weeks after the
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intervention (Ellis, Cushing, & Germain, 2015). Other studies using cognitive behavioral therapy
for insomnia also demonstrated a reduction of depressive symptoms in patients with comorbid
depression (e.g., Manber et al., 2008). Moreover, it has been suggested that sleep disruption
plays an important role, functioning as a transdiagnostic characteristic of mental disorders and
supporting the implementation of cognitive behavioral therapy modules for insomnia in the
treatment of a variety of disorders (e.g., Harvey et al., 2014). The present results support the
usefulness of such interventions, especially in participants with lower levels of resting CVC.
However, as our results indicate that having either high sleep quality or high CVC can protect
against greater depressive symptoms, treatment and preventive approaches may focus on
improving one of these factors depending on feasibility of the specific treatment and individual
preferences.
Limitations
This study has several limitations, including the use of a correlational design. Without investi-
gating causal manipulations or longitudinal data it is not possible to fully ascertain any cause-
effect assumptions in the examined models. Furthermore, the sample size is on the lower end for
reliably testing moderation or mediation models involving three variables. In spite of this, the
power for our whole moderation model (power = .99) as well as for the interaction term (power
= .73) is similar to the power described in El-Sheikh et al. (2007), at least for HF-HRV during
the prefilm baseline. It is also important to note that the present results replicated those reported
by El-Sheikh et al. (2007), adding to confidence in them. Nevertheless, extending and replicating
these findings using a longitudinal design and larger sample size (also including men and a
broader age range to enhance generalizability) will be important. We focused on overall sleep
quality and therefore used a well-validated self-report questionnaire for quantifying sleep quality,
which correlates with several objective measures of sleep quality (Akerstedt, Hume, Minors, &
Waterhouse, 1994). Nonetheless, it will be important to replicate the present pattern of results
with objective measures of sleep quality. This will make a careful selection of objective sleep
parameters necessary, as each single objective variable is not equivalent to overall subjective
sleep quality (e.g., Blunden & Galland, 2014). Lastly, although we explicitly focused on a
generally healthy sample to extend knowledge on how to improve mental health before clinical
disorders occur, findings may not necessarily reflect relations between variables in adults with
clinically significant depression or insomnia. Therefore, it is desirable to investigate this
moderation model in clinical samples.
CONCLUSION
To our knowledge, this is the first study investigating the interaction between CVC and sleep
quality in predicting mental health in a healthy adult population. Results demonstrated that
CVC and sleep quality interact such that higher depressive symptoms were only reported
when CVC (measured via HF-HRV) and sleep quality were both low. Reduced CVC seems to
constitute a marker for elevated depressive symptoms only in the context of low sleep quality
in healthy participants. Individuals’ high sleep quality may offset the risk imposed by
reduced CVC, consequently leading to decreased depressive symptomatology. These findings
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support enhanced CVC as a resilience factor for mental health, but they also point to a
protective function of high sleep quality for mental health in the context of reduced CVC.
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